Beijing Baimeite Biopharmaceutical Co., Ltd.

Baimeite Pharmaceutical is located in the capital city of Beijing, and is an enterprise group integrating drug R&D, manufacturing, commercial distribution, and investment. It has subordinate entities including Beijing Baimeite Pharmaceutical Co., Ltd., Beijing Baimeite Biopharmaceutical Co., Ltd., and an investment subsidiary. Beijing Baimeite Pharmaceutical Co., Ltd. was established in 2005 and has a history of seven years. It is a nationwide pharmaceutical sales and promotion enterprise dedicated to the R&D, production, sales, and promotion of drugs in the prescription drug field, including parenteral nutrition drugs, antibiotics, cardiovascular and cerebrovascular drugs, and anti-tumor chemotherapy drugs. It has established cooperative drug sales networks and direct sales offices in 29 provinces, autonomous regions, and municipalities directly under the central government. The company has its own modern pharmaceutical GSP logistics system and warehousing and transportation facilities. Since 2005, it has invested over 40 million yuan in the R&D of new drugs and generic drugs. Four new products have been launched, two are under application, and more than ten are under development. Fat emulsion infusions, amino acid infusions, and cephalosporin antibiotics are the current main products, with sales doubling consecutively in recent years, and sales revenue of 200 million yuan completed in 2010. After years of professionalized and standardized business management and continuous talent selection, we have developed an excellent management team. We have gathered a group of high-quality colleagues in marketing management, professional academic promotion, customer service, market education and training, financial management, human resource management, administrative management, production R&D management, quality management, warehousing and transportation management, and procurement management. We take "dedication, service, learning, and innovation" as the work requirements for each position in the enterprise, and "honesty, self-discipline, integrity, and kindness" as the personal requirements for employees. Our production and operation philosophy is "quality first, integrity-based". We adhere to the quality management philosophy of caring for life, prioritizing quality, prevention-oriented, continuous improvement, and striving for perfection. We maintain cGMP routine management, implement zero-defect quality projects, improve guarantee mechanisms, and provide high-quality products and services in a timely, orderly, and efficient manner, ensuring that ordinary people can obtain "affordable and reliable drugs". We hope that through these efforts, we can contribute to the progress of the domestic pharmaceutical industry. We will also continue our work in social welfare activities to give back to society; we will also continue our ongoing training and education activities for doctors and pharmacists in collaboration with professional domestic medical institutions. We hope to achieve the responsibility of improving domestic medical standards and benefiting society and patients through these actions. The group attaches great importance to new product development and has established a high-tech R&D base--Baimeite Biopharmaceutical Research Institute, equipped with advanced testing instruments and equipment, a comfortable working environment, and a complete scientific research innovation system centered on project incentive mechanisms. This has formed an R&D team with rich practical experience, including masters and bachelors. The R&D direction has been established, focusing on the development of products with new dosage forms and new technologies, comprehensively tracking domestic and international R&D information, and investing more than 5% of total sales revenue annually in new product development. While conducting independent R&D, we actively carry out scientific research cooperation with renowned domestic and international universities, research institutes, and famous enterprises, laying a solid foundation for the enterprise to become stronger, larger, and more enduring.